Japan to India: Guaifenesin Import Trade Route

The Japan to India Guaifenesin corridor is one of India's established pharmaceutical import routes from Japan, with 2 shipments documented worth a combined $8 USD. The route is dominated by SSP CO LIMITED, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Japan's guaifenesin export sector.

Across 1 active Japan suppliers, the average shipment value stands at $4 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 20.9%, placing it at rank #12 among India's top guaifenesin import origins globally.

On the Indian buyer side, key Indian importers include SANOFI HEALTHCARE INDIA PRIVATE LIMITED. SANOFI HEALTHCARE INDIA PRIVATE LIMITED is the single largest Indian importer with 2 shipments valued at $8 USD.

India's guaifenesin imports from Japan are driven primarily by a handful of large-scale Japan manufacturers. SSP CO LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Japan supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SSP CO LIMITED — together account for 100% of total trade value on this route. The average shipment value of $4 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as n.c.v. caffeine + chlorphenamine maleate + dihydrocodeinephosphate + guaifenesin syrup new bron solution-ace syrup, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Japan supplier.

On the buying side, SANOFI HEALTHCARE INDIA PRIVATE LIMITED is the largest importer with 2 shipments worth $8 USD — representing 100% of all guaifenesin imports from Japan on this route.